Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-10-31

FDA Approved: MESALAMINE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva Pharmaceuticals USA, Inc.'s original application for Mesalamine, a 5-aminosalicylic acid drug used in inflammatory bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)